Clinical Trial Update: Daridorexant for Alcohol Use Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating daridorexant for alcohol use disorder, sponsored by Johns Hopkins University, is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• Daridorexant (daridorexant)

Snippet

Sponsor: Johns Hopkins University | Conditions: Alcohol Use Disorder | Phase 2 | Status: NOT_YET_RECRUITING